DeDora Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $352K | Sell |
2,783
-107
| -4% | -$14.1K | 0.08% | 99 |
|
|
2026
Q1 | $403K | Hold |
2,890
| – | – | 0.1% | 88 |
|
|
2025
Q4 | $355K | Sell |
2,890
-121
| -4% | -$14.7K | 0.08% | 96 |
|
|
2025
Q3 | $334K | Hold |
3,011
| – | – | 0.08% | 100 |
|
|
2025
Q2 | $334K | Buy |
3,011
+1
| +0% | +$106 | 0.09% | 99 |
|
|
2025
Q1 | $337K | Sell |
3,010
-169
| -5% | -$17.4K | 0.1% | 95 |
|
|
2024
Q4 | $294K | Sell |
3,179
-34
| -1% | -$3.06K | 0.08% | 100 |
|
|
2024
Q3 | $269K | Sell |
3,213
-3,802
| -54% | -$290K | 0.08% | 101 |
|
|
2024
Q2 | $481K | Sell |
7,015
-156
| -2% | -$10.4K | 0.15% | 83 |
|
|
2024
Q1 | $525K | Sell |
7,171
-3,002
| -30% | -$231K | 0.17% | 78 |
|
|
2023
Q4 | $824K | Buy |
10,173
+59
| +0.6% | +$4.59K | 0.29% | 63 |
|
|
2023
Q3 | $758K | Buy |
10,114
+1,170
| +13% | +$90K | 0.3% | 62 |
|
|
2023
Q2 | $689K | Buy |
8,944
+251
| +3% | +$20K | 0.27% | 71 |
|
|
2023
Q1 | $721K | Buy |
8,693
+23
| +0.3% | +$1.91K | 0.31% | 69 |
|
|
2022
Q4 | $744K | Buy |
8,670
+521
| +6% | +$41.3K | 0.35% | 61 |
|
|
2022
Q3 | $503K | Sell |
8,149
-225
| -3% | -$14.2K | 0.26% | 70 |
|
|
2022
Q2 | $518K | Sell |
8,374
-8,873
| -51% | -$549K | 0.26% | 69 |
|
|
2022
Q1 | $1.02M | Buy |
+17,247
| New | +$1.1M | 0.41% | 52 |
|
|
2021
Q4 | – | Sell |
-15,044
| Closed | -$1.05M | – | 73 |
|
|
2021
Q3 | $1.05M | Buy |
15,044
+345
| +2% | +$24.2K | 0.46% | 47 |
|
|
2021
Q2 | $1.01M | Sell |
14,699
-72
| -0.5% | -$4.81K | 0.44% | 49 |
|
|
2021
Q1 | $955K | Buy |
14,771
+132
| +0.9% | +$8.51K | 0.45% | 48 |
|
|
2020
Q4 | $853K | Sell |
14,639
-707
| -5% | -$42.7K | 0.42% | 55 |
|
|
2020
Q3 | $970K | Buy |
15,346
+1,880
| +14% | +$130K | 0.54% | 48 |
|
|
2020
Q2 | $1.04M | Buy |
13,466
+859
| +7% | +$65.8K | 0.62% | 42 |
|
|
2020
Q1 | $942K | Sell |
12,607
-248
| -2% | -$17.1K | 0.71% | 41 |
|
|
2019
Q4 | $835K | Buy |
12,855
+735
| +6% | +$47.9K | 0.5% | 51 |
|
|
2019
Q3 | $768K | Sell |
12,120
-3,029
| -20% | -$198K | 0.53% | 48 |
|
|
2019
Q2 | $1.02M | Buy |
15,149
+517
| +4% | +$34K | 0.72% | 40 |
|
|
2019
Q1 | $951K | Buy |
14,632
+3,370
| +30% | +$224K | 0.72% | 37 |
|
|
2018
Q4 | $704K | Buy |
11,262
+5,573
| +98% | +$390K | 0.62% | 42 |
|
|
2018
Q3 | $439K | Sell |
5,689
-998
| -15% | -$75.4K | 0.33% | 54 |
|
|
2018
Q2 | $474K | Sell |
6,687
-379
| -5% | -$26.8K | 0.37% | 56 |
|
|
2018
Q1 | $533K | Sell |
7,066
-293
| -4% | -$23.3K | 0.43% | 50 |
|
|
2017
Q4 | $527K | Buy |
+7,359
| New | +$559K | 0.44% | 47 |
|
Other funds holding GILD
DeDora Capital's GILD Position: Q2 2026 in Review
DeDora Capital reduced its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, selling an estimated $14.1K and leaving 2,783 shares worth $352K. The position accounts for 0.08% of the portfolio, ranked #99.
DeDora Capital first reported a position in GILD in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.05M in Q3 2021. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- DeDora Capital held 2,783 shares of Gilead Sciences worth $352K as of Q2 2026.
- DeDora Capital sold 107 Gilead Sciences shares in Q2 2026, an estimated $14.1K.
- Gilead Sciences made up 0.08% of DeDora Capital's portfolio in Q2 2026, its #99 holding.
- DeDora Capital first reported a position in Gilead Sciences in Q4 2017 and has held it in 34 quarters since.
- DeDora Capital's Gilead Sciences position peaked at $1.05M in Q3 2021.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on DeDora Capital's 13F filing for Q2 2026, filed 13 Jul 2026.